XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 193,198 $ 1,908
Accounts receivable 193,094 0
Prepaid expenses and other assets 50,530 0
Income taxes refundable 35,399 0
Loan receivable from Emergence Global Enterprises Inc. - related party 0 17,901
Total current assets 472,221 19,809
Other assets    
Operating lease right-of-use assets 138,103 0
Other receivable 0 113,999
Note receivable - CEN Biotech Ukraine LLC - related party 44,859 44,859
Advances to CEN Biotech Ukraine LLC - related party 1,299,328 1,179,328
Property and equipment, net 97,403 0
Deferred income taxes (2,720) 0
Intangible assets, net (5,072,031) (4,956,147)
Goodwill 1,314,134 0
Total assets 8,440,799 6,314,142
Current liabilities    
Accounts payable 440,332 190,716
Accounts payable – related parties 101,422 8,347
Loans payable 1,688,793 527,379
Loans payable – related parties 2,701,641 1,363,354
Convertible notes payable, net of unamortized discount 643,330 6,652,448
Convertible notes payable, net of unamortized discount - related parties 162,639 2,558,681
Accrued interest 1,361,689 1,125,034
Accrued interest – related parties 1,873,455 1,615,880
Operating lease liabilities 103,908 22,895
Governmental assistance payable 145,333 0
Accrued expenses 638,073 641,023
Total current liabilities 9,860,615 14,705,757
Operating lease liabilities, less current portion 206,763 142,102
CEBA loan payable 31,552 0
Patent acquisition liability 0 1,380,000
Convertible notes, less current portion 0 78,000
Total liabilities 10,098,930 16,305,859
Commitments and contingencies (Notes 4, 11, 12, 18, 19, 24, and 25)
Shareholders’ deficit    
Common stock; unlimited authorized shares; 55,957,743 and 27,557,363 issued and outstanding as of December 31, 2021 and 2020, respectively. No par value. 0 0
Additional paid-in capital 44,339,973 17,068,810
Accumulated deficit (45,964,183) (27,060,527)
Accumulated other comprehensive loss (33,921) 0
Total shareholders’ deficit (1,658,131) (9,991,717)
Total liabilities and shareholders’ deficit $ 8,440,799 $ 6,314,142